Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Osugi

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Blood|September 28, 2002
Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytesYuko Osugi, Slavica Vuckovic, Derek N J Hart
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 7, 2010
[End of life care in children with cancer and problems--pediatric palliative care at hospital and home]Yuko Osugi, Takeshi Higashiura, Keiko Okada, et al.
Japanese Journal of Clinical Oncology|September 5, 2013
Phase I study of bevacizumab plus irinotecan in pediatric patients with recurrent/refractory solid tumorsKeiko Okada, Kai Yamasaki, Chika Tanaka, et al.
Pediatric Blood & Cancer|August 9, 2019
Double-conditioning regimen consisting of high-dose thiotepa and melphalan with autologous stem cell rescue for high-risk pediatric solid tumors: A second reportKeiko Okada, Kai Yamasaki, Chika Nitani, et al.
Journal of Adolescent and Young Adult Oncology|March 27, 2023
Development of an Online Communication Skills Training Program for Oncologists Working with Adolescents and Young AdultsMasako Okamura, Maiko Fujimori, Eiichi Saito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 28, 2012
[Successful treatment for thrombotic microangiopathy with recombinant human soluble thrombomodulin after umbilical cord blood transplantation]Keiko Okada, Asako Horino, Kai Yamasaki, et al.
Cureus|February 7, 2019
Usefulness of Quantitative Bone Single Photon Emission Computed Tomography/Computed Tomography for Evaluating Response to Neoadjuvant Chemotherapy in a Patient with Periosteal OsteosarcomaKazuhiro Kitajima, Hiroyuki Futani, Masayuki Fujiwara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 5, 2014
[Single institution experience of HLA-haploidentical hematopoietic stem cell transplantation for children: current problems and perspective]Keiko Okada, Yoshiko Nakano, Kai Yamasaki, et al.
International Journal of Hematology|June 22, 2006
Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantationYuko Osugi, Hiroshi Yamada, Gaku Hosoi, et al.
Pediatric Hematology and Oncology|June 24, 2008
A case series of children with high-risk metastatic neuroblastoma treated with a novel treatment strategy consisting of postponed primary surgery until the end of systemic chemotherapy including high-dose chemotherapyYoshiko Hashii, Takeshi Kusafuka, Hideaki Ohta, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Blood|September 28, 2002
Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytesYuko Osugi, Slavica Vuckovic, Derek N J Hart
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 7, 2010
[End of life care in children with cancer and problems--pediatric palliative care at hospital and home]Yuko Osugi, Takeshi Higashiura, Keiko Okada, et al.
Japanese Journal of Clinical Oncology|September 5, 2013
Phase I study of bevacizumab plus irinotecan in pediatric patients with recurrent/refractory solid tumorsKeiko Okada, Kai Yamasaki, Chika Tanaka, et al.
Pediatric Blood & Cancer|August 9, 2019
Double-conditioning regimen consisting of high-dose thiotepa and melphalan with autologous stem cell rescue for high-risk pediatric solid tumors: A second reportKeiko Okada, Kai Yamasaki, Chika Nitani, et al.
Journal of Adolescent and Young Adult Oncology|March 27, 2023
Development of an Online Communication Skills Training Program for Oncologists Working with Adolescents and Young AdultsMasako Okamura, Maiko Fujimori, Eiichi Saito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 28, 2012
[Successful treatment for thrombotic microangiopathy with recombinant human soluble thrombomodulin after umbilical cord blood transplantation]Keiko Okada, Asako Horino, Kai Yamasaki, et al.
Cureus|February 7, 2019
Usefulness of Quantitative Bone Single Photon Emission Computed Tomography/Computed Tomography for Evaluating Response to Neoadjuvant Chemotherapy in a Patient with Periosteal OsteosarcomaKazuhiro Kitajima, Hiroyuki Futani, Masayuki Fujiwara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 5, 2014
[Single institution experience of HLA-haploidentical hematopoietic stem cell transplantation for children: current problems and perspective]Keiko Okada, Yoshiko Nakano, Kai Yamasaki, et al.
International Journal of Hematology|June 22, 2006
Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantationYuko Osugi, Hiroshi Yamada, Gaku Hosoi, et al.
Pediatric Hematology and Oncology|June 24, 2008
A case series of children with high-risk metastatic neuroblastoma treated with a novel treatment strategy consisting of postponed primary surgery until the end of systemic chemotherapy including high-dose chemotherapyYoshiko Hashii, Takeshi Kusafuka, Hideaki Ohta, et al.
Pageof 4